SelectScience InterviewsLife Sciences
Quanterix CEO Discusses the Advantages of Monitoring Both Health and Disease in the Human Body
5 Apr 2017Kevin Hrusovsky is President and CEO of Quanterix, a company that is developing an ultrasensitive immunoassay platform that is capable of detecting very low levels of biomarkers in the body. Watch this exclusive interview to discover Hrusovsky’s vision for the future of healthcare.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
